as 11-21-2024 10:33am EST
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Founded: | 2010 | Country: | United States |
Employees: | N/A | City: | SAN FRANCISCO |
Market Cap: | 7.7B | IPO Year: | 2021 |
Target Price: | $50.43 | AVG Volume (30 days): | 2.2M |
Analyst Decision: | Buy | Number of Analysts: | 14 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.87 | EPS Growth: | 50.58 |
52 Week Low/High: | $22.96 - $61.75 | Next Earning Date: | 11-07-2024 |
Revenue: | $516,849,000 | Revenue Growth: | 15.29% |
Revenue Growth (this year): | 12.7% | Revenue Growth (next year): | 9.48% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Bryson Anna | DOCS | Chief Financial Officer | Nov 12 '24 | Sell | $58.61 | 100,000 | $5,842,248.05 | 304,506 | |
Wampler Kira Scherer | DOCS | Director | Nov 1 '24 | Sell | $42.00 | 2,500 | $105,000.00 | 16,618 | |
Cabral Timothy S | DOCS | Director | Nov 1 '24 | Sell | $42.07 | 20,000 | $841,306.00 | 11,074 | |
Wampler Kira Scherer | DOCS | Director | Oct 1 '24 | Sell | $43.44 | 2,500 | $108,600.00 | 16,618 | |
Wampler Kira Scherer | DOCS | Director | Sep 3 '24 | Sell | $36.27 | 2,500 | $90,675.00 | 16,618 |
DOCS Breaking Stock News: Dive into DOCS Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Zacks
a day ago
Zacks
2 days ago
Zacks
2 days ago
Insider Monkey
3 days ago
Zacks
6 days ago
Simply Wall St.
6 days ago
MT Newswires
7 days ago
The information presented on this page, "DOCS Doximity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.